August 2018 FDA Recall Drug by Mylan Pharmaceuticals Inc.
D-0025-2019 - Labeling

This Class III drug recall was voluntarily initiated by Mylan Pharmaceuticals Inc. on August 27, 2018 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed in Product was distributed throughout the United States. and the recall is currently terminated.

Recall Number: D-0025-2019

Reason for Recall
Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs.
Initiated
08-27-2018
Reported
10-24-2018
Quantity
5,790 cartons (526,890 tablets)

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Mylan Pharmaceuticals Inc.
Product was distributed throughout the United States.
Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg, Rx Only, 3 extended-cycle blister packs containing 91 tablets each, Made in India, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-7281-53.

Batch or Lot Expiration Information

Lot# 8508F004A; Exp. 02/20